Hypaque-1077 (Sigma-Aldrich, Gillingham, UK) was used to isolate peripheral blood mononuclear cells (PBMCs) of SCLC patients and healthy controls. The isolated cells were re-suspended in
RPMI-1640 medium (Biosera, Heathfield, UK), supplemented with 10%
heat-inactivated fetal bovine serum (Gibco, Grand Island, NY, USA) and 1%
penicillin and streptomycin (Solarbio, Beijing, China). PBMCs were frozen in
RPMI-1640 medium supplemented with 20%
FBS and 10%
DMSO (Sigma-Aldrich, Gillingham, UK) and stored at −80 °C until flow cytometric analysis.
PBMCs were stained for the expression of surface markers using the following anti-human fluorochrome-conjugated monoclonal antibodies:
anti-CD3 PE-Cy7;
anti-CD4 BV510;
anti-CD8 APC-Cy7;
anti-CD45RA PE;
anti-CD45RO APC;
anti-CCR7 FITC;
anti-PD-1 PerCPCy5.5; and
anti-PD-L1 BV421 (all antibodies were purchased from Biolegend, San Diego, CA, USA). Staining was performed in FACS buffer, 1% PBS-BSA, for 30 min, on ice, in the dark. Acquisition and multicolor analysis were performed using BD FACSChorus Software version 3.0. on a
Melody flow cytometer (BD Biosciences, Heidelberg, Germany). For T-cell subsets, the analysis gates were restricted to the lymphocytic population. Each measurement contained 10
6 single events. Unstained cells were used as negative control, whereas FMO-stained cells were used in order to set the gates.
Xagara A., Roumeliotou A., Kokkalis A., Tsapakidis K., Papakonstantinou D., Papadopoulos V., Samaras I., Chantzara E., Kallergi G, & Kotsakis A. (2024). ES-SCLC Patients with PD-L1+ CTCs and High Percentages of CD8+PD-1+T Cells in Circulation Benefit from Front-Line Immunotherapy Treatment. Biomedicines, 12(1), 146.